In an interview with OncLive®, Guru Sonpavde, MD, discussed topline data from an exploratory analysis of quality of life (QOL) outcomes in the phase...
SGLT2 inhibitors, which are a type of medication to treat diabetes, may reduce the risk for neurodegenerative conditions, including Parkinson’s disease and dementia, a...
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Morning! Today, we discuss...